Heart Failure - Systolic Dysfunction [update 2019]
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
Health care systems have targeted HF as a medical condition needing better disease-based management because of its prevalence and its management costs. Treatment guidelines have evolved to improve the standardization of care using evidence-based approaches. This guideline-based, self-study activity provides practical guidance to clinicians about managing heart failure due to systolic dysfunction. A framework of symptom severity guides pharmacologic treatment of these patients.
The University of Michigan Medical School designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date:February 2017
Termination Date: June 2022
Continued availability of CME credit for this activity depends on a thorough review of its content every three years. This activity was last reviewed for currency and accuracy in June 2019, and availability of CME credit continued.
William E. Chavey, MD; Family Medicine
Barry E. Bleske, PharmD; Pharmacy
R. Van Harrison, PhD; Medical Education
Robert V. Hogikyan, MD, MPH; Geriatric Medicine
Yeong Kwok, MD; General Medicine
John M. Nicklas, MD; Cardiology
Todd M. Koelling, MD; Cardiology
Financial Disclosure Information:
Barry Bleske, PharmD
Speaker's Bureau: Boehringer Ingelheim, Otsuka
Research Funding: Otsuka
There are no other relevant financial relationships to disclose for this CME activity.
UMHS Guidelines Oversight Team:
Karl T Rew, MD
R. Van Harrison, PhD
Literature Search Services:
Taubman Health Sciences Library